Analyst Ratings for Bristol-Myers Squibb Co. (BMY)

Updated: 2017-07-28

Bristol-Myers Squibb Co. (NYSE:BMY) was awarded an average rating of Overweight from investment analysts following the stock. Last month, BMY received an average rating of Overweight.

24 analysts issued ratings on the stock, where 10 gave BMY a buy rating, 1 gave an overweight rating, 10 issued a hold rating, 1 issued an underweight rating, and 2 gave a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 1.

BMY was given price targets by several analysts. The highest price target was 68, implying potential capital gains of 25.37 percent. The minimum price target given was 40, implying a possible loss of -26.25 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Analysts have revised their earnings estimates upwards for this quarter, by about 0.68 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is 4.27 percent. Meanwhile, fiscal year estimates have been revised upwards by 0.34 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 3.53 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. 3 analysts made positive revisions to their quarterly estimates over the past month, while 4 analysts revised their estimates downwards. Over the same time period, 4 analysts revised their FY earnings estimates upwards, compared to 3 analysts that revised their FY estimates downwards.

Analysts estimate earnings of BMY to grow at a rate of 3.52 percent. Another measure frequently examined by investors is the PEG ratio. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. PEG ratios below 1 are often considered desirable, although it is frequently more appropriate to compare PEG ratios to the company's peers. BMY has a PEG ratio of 5.6.

In the trailing 52-weeks, BMY hit 76.48 at the highest peak, while it's lowest trading point was 46.01. The current market price is above the trailing year's low by 17.89 percent, and 29.08 percent below the high. BMY has a P/E ratio of 19.72. Investors typically compare the P/E ratio to a company's peers in the industry. The BMY value stock report compares BMY to some of its peers using value stock charts. The market cap of BMY is $92.22 billion. BMY will post this quarters earnings in days, on 0000-00-00.